help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peng, X.
Right arrow Articles by Kreider, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, X.
Right arrow Articles by Kreider, J. W.
(American Journal of Pathology. 1999;155:315-324.)
© 1999 American Society for Investigative Pathology

Animal Model

Development of Keratoacanthomas and Squamous Cell Carcinomas in Transgenic Rabbits with Targeted Expression of EJras Oncogene in Epidermis

Xuwen Peng*, James W. Griffith*, Ricai Han{dagger}, C. Max Lang* and John W. Kreider{dagger}{ddagger}

Department of Comparative Medicine,*
Jake Gittlen Cancer Research Institute,{dagger}
and Department of Microbiology and Immunology,{ddagger}
The Milton S. Hershey Medical Center of The Pennsylvania State University, Hershey, Pennsylvania

Activated ras genes have been frequently identified in both benign and malignant human tumors, including keratoacanthoma and squamous cell carcinoma. In this study, we developed two lines of transgenic rabbits in which the expression of EJras has been specifically targeted to the rabbit epidermal keratinocytes, using the upstream regulatory region of cottontail rabbit papillomavirus. All of the F1 transgenic progenies developed multiple keratoacanthomas at about 3 days after birth. The rabbits developed an average of 20 tumors, which usually reached the size of approximately 1 cm in diameter and then spontaneously regressed in about 2 months, similar to keratoacanthoma regression in humans. In addition, up to 18% of the rabbits then developed squamous cell carcinoma at about 5 months of age. The expression of EJras was detectable in all of the keratoacanthomas and squamous cell carcinomas. These results strongly support the involvement of the ras oncogene in both the initiation and regression of keratoacanthoma, and in the development of squamous cell carcinomas. These novel transgenic rabbits, with their consistent tumorigenic phenotype at an early age, high similarity to the human lesions, and easy accessibility for examination, manipulation, biopsy, and treatment, should provide a unique model system for studying ras activation-related tumor initiation, regression, and progression, and for evaluating antitumor therapies.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
J. Hu, X. Peng, T. D. Schell, L. R. Budgeon, N. M. Cladel, and N. D. Christensen
An HLA-A2.1-Transgenic Rabbit Model to Study Immunity to Papillomavirus Infection
J. Immunol., December 1, 2006; 177(11): 8037 - 8045.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. D. Billings, M. D. Southall, T. Li, P. W. Cook, L. Baldridge, W. B. Moores, D. F. Spandau, J. G. Foley, and J. B. Travers
Amphiregulin Overexpression Results in Rapidly Growing Keratinocytic Tumors: An In Vivo Xenograft Model of Keratoacanthoma
Am. J. Pathol., December 1, 2003; 163(6): 2451 - 2458.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
K. R. Martin, C. Trempus, M. Saulnier, F. W. Kari, J.C. Barrett, and J. E. French
Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice
Carcinogenesis, September 1, 2001; 22(9): 1373 - 1378.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.